tirzepatide clinical trial weight loss results after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 Tirzepatide for Medical Weight Loss

"What do you do to fill the void?" Semaglutide is making people miss their favorite foods Semaglutide, sold under the brand names Wegovy and Ozempic, is an injectable drug that boosts the production of insulin, a hormone that helps regulate blood sugar

El resultado: mejor control de la glicemia y reduccin significativa del peso corporal por cambios en la conducta alimentaria

It should also be avoided during pregnancy and breastfeeding, as well as being used with caution in patients with a history of pancreatitis or severe gastrointestinal disease

--- The Bottom Line The 87.5% responder rate at 12 months is a meaningful data point

For a broader comparison between the two major GLP-1 medications, see our semaglutide versus tirzepatide comparison

Companies like Peptide Sciences have built their reputation on extensive testing documentation over many years